CardioKinetix

CardioKinetix, Inc. develops transcatheter implants. Its product portfolio includes Parachute, a ventricular partitioning device designed to treat heart failure caused by cardiac disease by improving overall cardiac function. The company's Parachute is deployed in the left ventricle for patients with ischemic left-sided heart failure following a heart attack. It primarily serves customers in the United States, France, Germany, Latvia, Portugal, Serbia, Slovenia, the Netherlands, and the United Kingdom.